Pelthos Therapeutics Inc (PTHS)

$26.01 -1.23 (-4.52%)
Market Cap 90.10M
Revenue (ttm) 16.80M
Net Income (ttm) -43.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -257.86%
Debt to Equity Ratio 0.00
Volume 44,156
Avg Vol 12,550
Day's Range N/A - N/A
Shares Out 3.36M
Stochastic %K 92%
Beta 3.29
Analysts Strong Sell
Price Target $57.14

Company Profile

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indi...

Industry: Biotechnology
Sector: Healthcare
Phone: 919 908 2400
Website: pelthos.com
Address:
4020 Stirrup Creek Drive, Suite 110, Durham, United States
mateo86
mateo86 May. 13 at 9:59 PM
$PTHS ER must have missed.... Jesus what a swing in price today
0 · Reply
JFais
JFais May. 13 at 1:58 PM
$PTHS $22 to $28 move since posted thesis (NP)
0 · Reply
twib
twib May. 13 at 5:14 AM
$PTHS I hate to cross post but it so slow here...anyway, do some dd on SLS! 2 great drugs imo with one(gps) trial due anyday now(tmrw til maybe 2 mo timespan)and the 2nd destroys the common binary nature of bios by being a 1st in class imo cdk9 inhibitor in trials showing no adverse reactions/safety concerns and solid efficacy. **No rev bio so play safely**
0 · Reply
Jwa68
Jwa68 May. 13 at 2:10 AM
$PTHS Progress over perfection. Target in the low $40's with continued execution.
0 · Reply
twib
twib May. 12 at 9:52 AM
$PTHS What, premarket movement? Prob only 2 shares but i dont kniw if I've seen that b4. 👀🤔
0 · Reply
SuperGreenToday
SuperGreenToday May. 12 at 3:33 AM
$PTHS
0 · Reply
twib
twib May. 12 at 1:00 AM
$PTHS Boring but I'll tske our slow rise from $20.Im curious to see what kinda vol they get if put up with a decent er.
0 · Reply
Jwa68
Jwa68 May. 11 at 8:47 PM
$PTHS Nice day. Still half off sale. Boring but great management and execution.
0 · Reply
twib
twib May. 11 at 6:43 PM
$PTHS Prob end the day with 8x avg vol! Small but someone smart said its all relative. Getting ready for er boost imo!🤞
0 · Reply
twib
twib May. 11 at 7:57 AM
$PTHS Read may 14th next er! Thats this thurs. 🤞👍
0 · Reply
Latest News on PTHS
Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026

May 1, 2026, 8:30 AM EDT - 12 days ago

Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026

Pelthos Therapeutics says John Gay to succeed Francis Knuettel II as CFO

2026-04-10T21:05:40.000Z - 4 weeks ago

Pelthos Therapeutics says John Gay to succeed Francis Knuettel II as CFO

Pelthos Therapeutics initiated with an Overweight at Cantor Fitzgerald

2026-04-01T11:03:03.000Z - 6 weeks ago

Pelthos Therapeutics initiated with an Overweight at Cantor Fitzgerald

Pelthos Therapeutics initiated with an Overweight at Cantor Fitzgerald

2026-04-01T10:05:12.000Z - 6 weeks ago

Pelthos Therapeutics initiated with an Overweight at Cantor Fitzgerald

Pelthos Therapeutics doses first patient in CT2000 trial

2026-03-31T14:21:12.000Z - 6 weeks ago

Pelthos Therapeutics doses first patient in CT2000 trial

Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain

Mar 31, 2026, 8:30 AM EDT - 6 weeks ago

Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain

Pelthos Therapeutics Transcript: The 38th Annual Roth Conference

Mar 23, 2026, 6:00 PM EDT - 7 weeks ago

Pelthos Therapeutics Transcript: The 38th Annual Roth Conference

Pelthos Therapeutics Inc trading resumes

2026-03-23T15:15:22.000Z - 7 weeks ago

Pelthos Therapeutics Inc trading resumes

Pelthos Therapeutics Inc trading halted, volatility trading pause

2026-03-23T15:10:12.000Z - 7 weeks ago

Pelthos Therapeutics Inc trading halted, volatility trading pause

Pelthos Therapeutics price target raised to $62 from $60 at Oppenheimer

2026-03-20T11:35:30.000Z - 7 weeks ago

Pelthos Therapeutics price target raised to $62 from $60 at Oppenheimer

Pelthos Therapeutics Earnings Call Transcript: Q4 2025

Mar 19, 2026, 8:00 AM EDT - 7 weeks ago

Pelthos Therapeutics Earnings Call Transcript: Q4 2025

Pelthos Therapeutics reports Q4 EPS ($6.87) vs. ($3.19) last year

2026-03-19T10:35:13.000Z - 7 weeks ago

Pelthos Therapeutics reports Q4 EPS ($6.87) vs. ($3.19) last year

Pelthos Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results

Mar 19, 2026, 6:30 AM EDT - 7 weeks ago

Pelthos Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results

Pelthos Therapeutics to Present at 38th Annual ROTH Conference

Mar 12, 2026, 8:30 AM EDT - 2 months ago

Pelthos Therapeutics to Present at 38th Annual ROTH Conference

Pelthos Therapeutics initiated with an Overweight at Piper Sandler

2026-02-27T10:05:51.000Z - 2 months ago

Pelthos Therapeutics initiated with an Overweight at Piper Sandler

Pelthos Therapeutics Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference

Feb 26, 2026, 10:00 AM EST - 2 months ago

Pelthos Therapeutics Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference

Pelthos Therapeutics price target lowered to $55 from $57 at Roth Capital

2026-02-26T00:55:12.000Z - 2 months ago

Pelthos Therapeutics price target lowered to $55 from $57 at Roth Capital

Pelthos Therapeutics files $200M mixed securities shelf

2026-02-02T21:50:24.000Z - 3 months ago

Pelthos Therapeutics files $200M mixed securities shelf

Pelthos Therapeutics price target raised to $60 from $57 at Oppenheimer

2026-01-26T13:26:13.000Z - 3 months ago

Pelthos Therapeutics price target raised to $60 from $57 at Oppenheimer

Horizon Technology provides $50M loan facility to Pelthos Therapeutics

2026-01-15T21:15:23.000Z - 4 months ago

Horizon Technology provides $50M loan facility to Pelthos Therapeutics

HRZN

Horizon Technology Finance Provides up to $50 Million Venture Loan Facility to Pelthos Therapeutics

Jan 15, 2026, 4:10 PM EST - 4 months ago

Horizon Technology Finance Provides up to $50 Million Venture Loan Facility to Pelthos Therapeutics

HRZN

Pelthos Therapeutics secures up to $50M senior secured term loan

2026-01-13T13:50:50.000Z - 4 months ago

Pelthos Therapeutics secures up to $50M senior secured term loan

HRZN

Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance

Jan 13, 2026, 8:30 AM EST - 4 months ago

Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance

Pelthos Therapeutics acquires Xeglyze topical treatment for $1.8M

2026-01-05T12:35:38.000Z - 4 months ago

Pelthos Therapeutics acquires Xeglyze topical treatment for $1.8M

Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice

Jan 5, 2026, 7:30 AM EST - 4 months ago

Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice

Pelthos Therapeutics Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 4, 2025, 9:30 AM EST - 5 months ago

Pelthos Therapeutics Transcript: Piper Sandler 37th Annual Healthcare Conference

Pelthos signs benefit manager agreement expanding patient access to ZELSUVMI

2025-12-04T12:05:10.000Z - 5 months ago

Pelthos signs benefit manager agreement expanding patient access to ZELSUVMI

Lake Street starts Pelthos with a Buy on ‘category-leader potential’

2025-12-03T14:05:36.000Z - 5 months ago

Lake Street starts Pelthos with a Buy on ‘category-leader potential’

Pelthos Therapeutics initiated with a Buy at Lake Street

2025-12-03T13:15:27.000Z - 5 months ago

Pelthos Therapeutics initiated with a Buy at Lake Street

Pelthos Therapeutics initiated with a Buy at H.C. Wainwright

2025-12-03T11:15:50.000Z - 5 months ago

Pelthos Therapeutics initiated with a Buy at H.C. Wainwright

Pelthos Therapeutics initiated with a Buy at Roth Capital

2025-11-25T09:30:19.000Z - 6 months ago

Pelthos Therapeutics initiated with a Buy at Roth Capital

Pelthos Therapeutics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 8:00 AM EST - 6 months ago

Pelthos Therapeutics Earnings Call Transcript: Q3 2025

Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results

Nov 13, 2025, 6:45 AM EST - 6 months ago

Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results

Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing

Nov 7, 2025, 8:00 AM EST - 6 months ago

Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing

Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025

Nov 5, 2025, 8:00 AM EST - 6 months ago

Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025

Pelthos Therapeutics to Participate in Upcoming September Investor Conferences

Sep 8, 2025, 8:30 AM EDT - 8 months ago

Pelthos Therapeutics to Participate in Upcoming September Investor Conferences

Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update

Aug 18, 2025, 8:00 AM EDT - 9 months ago

Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update

mateo86
mateo86 May. 13 at 9:59 PM
$PTHS ER must have missed.... Jesus what a swing in price today
0 · Reply
JFais
JFais May. 13 at 1:58 PM
$PTHS $22 to $28 move since posted thesis (NP)
0 · Reply
twib
twib May. 13 at 5:14 AM
$PTHS I hate to cross post but it so slow here...anyway, do some dd on SLS! 2 great drugs imo with one(gps) trial due anyday now(tmrw til maybe 2 mo timespan)and the 2nd destroys the common binary nature of bios by being a 1st in class imo cdk9 inhibitor in trials showing no adverse reactions/safety concerns and solid efficacy. **No rev bio so play safely**
0 · Reply
Jwa68
Jwa68 May. 13 at 2:10 AM
$PTHS Progress over perfection. Target in the low $40's with continued execution.
0 · Reply
twib
twib May. 12 at 9:52 AM
$PTHS What, premarket movement? Prob only 2 shares but i dont kniw if I've seen that b4. 👀🤔
0 · Reply
SuperGreenToday
SuperGreenToday May. 12 at 3:33 AM
$PTHS
0 · Reply
twib
twib May. 12 at 1:00 AM
$PTHS Boring but I'll tske our slow rise from $20.Im curious to see what kinda vol they get if put up with a decent er.
0 · Reply
Jwa68
Jwa68 May. 11 at 8:47 PM
$PTHS Nice day. Still half off sale. Boring but great management and execution.
0 · Reply
twib
twib May. 11 at 6:43 PM
$PTHS Prob end the day with 8x avg vol! Small but someone smart said its all relative. Getting ready for er boost imo!🤞
0 · Reply
twib
twib May. 11 at 7:57 AM
$PTHS Read may 14th next er! Thats this thurs. 🤞👍
0 · Reply
Jwa68
Jwa68 May. 6 at 11:42 AM
$PTHS Still...
1 · Reply
JFais
JFais Apr. 28 at 4:13 PM
$PTHS (NP) Breaking out last couple days Perhaps too low volume for the Core Biotech portfolio, but I shared this one in our most recent Playbook post (potential setups on radar) Hat tip to @plainyogurt21 for flagging
0 · Reply
Jwa68
Jwa68 Apr. 27 at 10:17 PM
$PTHS Still very undervalued.
1 · Reply
mateo86
mateo86 Apr. 22 at 7:07 PM
$PTHS anyone have access to recent script numbers? Please and thank you
1 · Reply
twib
twib Apr. 16 at 5:56 PM
$PTHS Think we've disappeared from mkt:) At least on st I havent seen it move even a penny off $23. 🤯🤦‍♂️
0 · Reply
twib
twib Apr. 15 at 1:54 PM
$PTHS One 100 shr buy tday, the rest are all 1 shr. 181 in 1st half hour. Waiting for the day our little baby will get noticed.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 9 at 10:48 PM
$PTHS RSI: 48.54, MACD: -0.2166 Vol: 1.24, MA20: 22.55, MA50: 22.89 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
twib
twib Apr. 6 at 7:44 PM
$PTHS Up large tday on 3x avg volume. Jw apprec the #s as always. We movin😯
0 · Reply
Jwa68
Jwa68 Apr. 6 at 5:48 PM
$PTHS 834 units the week before last. Up 10% from the prior week. Executing!!
2 · Reply
twib
twib Apr. 6 at 3:28 PM
$PTHS 😁 This will eventually get volume flow up. Guessing very little tday causing. Might need to have patience for a good yr or so but...
1 · Reply
Jwa68
Jwa68 Apr. 1 at 2:16 PM
$PTHS Cantor note out, very bullish. "Under the radar commercial launch story that is starting to inflect and we believe the current valuation does not reflect it at all." Target $50
0 · Reply
Jwa68
Jwa68 Mar. 31 at 1:09 PM
$PTHS Continued execution by management. Shares remain very undervalued.
0 · Reply